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Background
Medical research advances the knowledge and practice of 
clinical medicine, but public participation in medical research 
in the United States is low.1 Many US trials experience slow 
or insufficient enrollment and therefore incur greater-than-
expected costs and may fail to meet enrollment goals entirely.2 
The consequences on clinical care are profound: recently the 
Institute of Medicine reported that “fewer than 15% of major 
recommendations in clinical practice guidelines in infectious 
disease and cardiovascular disease are based on solid evidence.”2
Moreover, racial/ethnic minorities are underrepresented in 
clinical trials. In order to tackle continuing health disparities,3 
research and public research participation must include racial/
ethnic minority groups who are often disproportionately affected 
by diseases such as stroke, heart disease, and HIV/AIDS.4 Since 
1993, the NIH has called for more balanced representation of 
the nation’s population in clinical trials,5 and a large body of 
subsequent literature has identified attitudes, barriers, facilitators, 
and methods to increase specific populations’ participation in 
clinical research.6–14 However, existing evidence about public 
participation in research commonly focuses on disease-specific 
and/or minority group patterns,15–19 rather than taking a national 
perspective.
In this study, we examine the public’s interest in medical 
research participation (MRP) in a nationally representative 
sample, with oversampling of racial/ethnic minorities in order 
to obtain robust estimates of their perspectives. We also address 
the challenge of understanding low public research participation 
rates by examining public interest in MRP by study type. The 
purpose of this study was to determine the public’s interest in 
MRP, and factors associated with MRP as a healthy volunteer 
with low risks or as a person with a specific condition. A second 
objective was to characterize in which type of medical research, 
ranging from survey questions to DNA sampling, the public is 
most likely to participate.
Methods
Study sample
This was a nationally representative, cross-sectional, Web-based 
survey of the US population, conducted in June 2012. GfK/
Knowledge Networks fielded the survey using a Web-enabled 
Knowledge Panel that includes cell-phone-only households,20 
employing a 50-state sampling approach that has served as the 
basis for several peer-reviewed publications.20–25 GfK/Knowledge 
Networks uses probability-based sampling of US Postal Service 
delivery addresses and provides Internet access for those who 
wish to participate but do not have computer hardware or Internet 
access at the time of initial contact; this provision ensures that 
the study includes households from a wide range of age groups, 
racial/ethnic groups, and income strata who have different a priori 
probabilities of being Web-enabled households. Households using 
their own computers and Internet access to complete the survey 
are enrolled in a points program. At the completion of the survey, 
Knowledge Panelists received incentive points that are redeemable 
for gift cards, merchandise, or cash.
Survey respondents reported sociodemographic 
information, including age, gender, education, household 
income, insurance status, and race/ethnicity. The investigators 
designed survey items used in other published work,1 and 
included questions about interest in MRP as a healthy volunteer 
exposed to low risks and if diagnosed with the disease being 
studied (described hereafter as “diagnosed volunteer”). Using 
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separate questions, we inquired about likelihood of participating 
in seven different study types, selected by the investigators to 
span a wide variety of project foci: trials of medications, trials 
of vaccines, trials of medical devices, tests of DNA/genetic 
material with information stored in a confidential file, questions 
about nutrition/eating, questions about behavior, and questions 
about mental health. The survey items presented hypothetical 
scenarios and asked about respondent levels of interest in MRP 
based on the scenario.
For purposes of logistic regression analysis described 
below, we collapsed the 3-category response options (very likely, 
somewhat likely, not likely) or (yes, no, unsure) into 2 categories 
(likely, not likely) or (yes, no), respectively.
Statistical analyses
We used descriptive statistics to estimate the proportion of 
respondents who would consider MRP as healthy volunteers 
exposed to low risks and as diagnosed volunteers. Subsequently, 
we focused on the types of studies that respondents would 
participate in as diagnosed volunteers.
We used bivariate and multivariate logistic regression to 
determine if there were associations for these outcome variables 
across the following respondent-level predictors: age, gender, 
race/ethnicity, annual household income, education, health 
insurance type, and employment status at the time of survey 
administration.
The survey partner, GfK/Knowledge Networks, provided 
sampling weights that we incorporated in all analyses to generate 
nationally representative estimates for all analyses using Stata, 
version 12 (Stata Corporation, College Station, TX, USA).
Results
Overall, 2,668 adults participated in this study (response rate 61%). 
The majority of participants (75.1%) reside in households with 
their own computers and Internet connectivity. The characteristics 
of the study sample are presented in Table 1.
Interest in MRP by volunteer status
About two out of every five respondents (41%) expressed that they 
would consider MRP if asked to do so as a healthy volunteer if the 
risks were low. There were no statistically significant differences 
in likelihood of MRP as a healthy volunteer associated with 
respondent age, gender, race/ethnicity, annual household income, 
health insurance type, and employment status. Respondents with 
higher education levels indicated higher odds of interest in MRP 
as healthy volunteers (Table 2).
In comparison, three of every five respondents (60%) indicated 
interest in MRP if they were invited to do so as diagnosed 
volunteers. In multivariate analyses, non-Hispanic black race 
and less than high school education were associated with lower 
odds of interest in MRP as a diagnosed volunteer compared with 
non-Hispanic white race and high school education, respectively 
(Table 3).
Likelihood of MRP by study type
Respondents were asked about the likelihood of MRP in different 
study types as diagnosed volunteers. Varying proportions of 
respondents indicated that they were likely to participate in each 
study type, with most respondents likely to answer questions 
about nutrition or eating, and the fewest likely to participate in 
a vaccine trial (Table 4).
Multivariate analyses of likelihood of MRP as a diagnosed 
volunteer across respondent age, gender, race/ethnicity, household 
income, education, employment status at survey time, and 
insurance type were conducted. For trials of medication, non-
Hispanic black race was associated with lower odds of interest in 
MRP compared with non-Hispanic white respondents (Table 5). 
Otherwise, there were no differences in likelihood of MRP by 
race/ethnicity.
For other types of studies, there were differences in 
likelihood of MRP related to education and insurance 
status. For studies involving questions about nutrition or 
eating, respondents with bachelor degrees or higher were 
significantly more likely than respondents with only high 
Age of respondents (years)
 18–29 18%
 30–44 27%
 45–59 29%
 60+ 26%
Gender
 Male 48%
 Female 52%
Race/ethnicity
 White, non-Hispanic 69%
 Black, non-Hispanic 11%
 Hispanic 13%
 Other, non-Hispanic 7%
Education
 Less than high school 11%
 High school 30%
 Some college 29%
 Bachelors degree or higher 30%
Annual household income
 Up to $24,999 19%
 $25,000–$49,999 24%
 $50,000–$99,999 35%
 $100,000 or more 23%
Health insurance at time of survey completion
 Private 55%
 Public 27%
 Other 5%
 None 14%
Employment status at survey time
 Working 56%
 Not working—retired 18%
 Not working—disabled 7%
 Not working—other 18%
*Proportions within individual variables may not sum to 100% because of rounding.
Table 1. Characteristics of study respondents (n = 2,668)*.
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school education to say they were likely to participate. For 
studies involving questions about nutrition or eating and 
questions about behavior, respondents with no insurance 
coverage were significantly less likely than respondents with 
private insurance to say they were likely to participate. For 
studies involving questions about behavior or that collect a 
DNA sample for databank entry, respondents with less than 
high school education were significantly less likely than those 
with only high school education to indicate they were likely 
to participate (data not shown; available from the authors 
upon request).
Discussion
To our knowledge, this is the first study to 
examine rates of US public interest in MRP 
at the national level without regard to disease 
processes or clinical settings, and to further 
characterize that interest across a variety 
of study types. This analysis provides new 
perspectives to inform national dialogue 
about the clinical trials enterprise.
Our main finding was that just under 
one-half of this nationally representative 
sample is interested in MRP as healthy 
volunteers if the risks were low—and that 
higher proportions of adults would consider 
participation as diagnosed volunteers 
rather than as healthy volunteers. This is a 
novel finding that has not been previously 
reported. By contrast, the rate of prior MRP 
nationally is markedly lower at 11%.1 There 
were no differences in interest in MRP as 
a health volunteer by age, race/ethnicity, 
annual household income, and health 
insurance type. However, respondents with 
more than high school education expressed 
greater interest in MRP than their peers. 
Our findings suggest that there are many 
willing and interested potential research 
participants who would consider MRP if 
they were invited.
To broaden participation in future 
medical research efforts, reasons for 
underenrollment in current trials26 must 
be identified, including issues related to 
awareness, access, and eligibility. Another 
key aspect of enrollment highlighted in 
this study is the type of research involved, 
and the finding that very common types of 
research involving medications and medical 
devices were the study formats least likely to 
appeal to the public. Importantly, nutrition 
and behavioral research that can illuminate 
key etiologies of diseases such as obesity, 
heart disease, and diabetes mellitus were 
the study types most likely to appeal to the 
public. Another way to view these findings 
is that respondents were more interested in 
MRP that is less invasive, and potentially 
poses less individual risk. Cottler et al. 
found similar results in a seven-site study of 
community members’ perceptions of health 
research when polled by community health workers,27 although 
their inquiry did not examine as many different types of research 
as we asked respondents to consider in this study.
We found that non-Hispanic blacks expressed significantly 
less interest than non-Hispanic whites in MRP as diagnosed 
volunteers. We also found that non-Hispanic blacks endorsed 
less interest than non-Hispanic whites if MRP involved testing 
a medication, and similar levels of interest as non-Hispanic 
whites for genetic studies. Consistent with our findings, 
Braunstein found that blacks were less willing to participate in 
cardiovascular drug trials and that blacks carried a greater level of 
Unadjusted odds ratio 
(95% CI)
Adjusted* odds ratio 
(95% CI)
Age (years)
 18–29 1.0 (ref) 1.0 (ref)
 30–44 1.17 (0.79) 1.04 (0.68)
 45–59 1.03 (0.68) 1.01 (0.65)
 ≥60 0.89 (0.44) 0.89 (0.48)
Gender
 Male 1.0 (ref) 1.0 (ref)
 Female 0.94 (0.73–1.22) 0.95 (0.72–1.25)
Race/ethnicity
 White, non-Hispanic 1.0 (ref) 1.0 (ref)
 Black, non-Hispanic 0.72 (0.48–1.07) 0.71 (0.47–1.06)
 Hispanic 1.03 (0.68–1.56) 1.11 (0.70–1.76)
 Other, non-Hispanic 0.87 (0.51–1.50) 0.74 (0.43–1.27)
Education
 Less than high school 0.66 (0.40–1.08) 0.63 (0.38–1.06)
 High school 1.0 (ref) 1.0 (ref)
 Some college 1.56 (1.11–2.20) 1.54 (1.09–2.19)
 Bachelors degree or higher 1.96 (1.40–2.75) 1.86 (1.29–2.70)
Household income
 Up to $24,999 1.0 (ref) 1.0 (ref)
 $25,000–$49,999 0.69 (0.46–1.04) 0.60 (0.39–0.93)
 $50,000–$99,999 0.95 (0.65–2.15) 0.74 (0.47–1.17)
 $100,000 or more 1.40 (0.93–2.10) 0.90 (0.55–1.49)
Health insurance at time of survey completion
 Private 1.0 (ref) 1.0 (ref)
 Public 0.69 (0.51–0.94) 1.04 (0.70–1.54)
 Other 0.80 (0.37–1.69) 1.00 (0.44–2.28)
 None 0.83 (0.56–1.24) 0.97 (0.62–1.51)
Employment status at the time of survey completion
 Working 1.0 (ref) 1.0 (ref)
 Not working—retired 0.57 (0.38–0.84) 0.69 (0.40–1.20)
 Not working—disabled 0.77 (0.46–1.30) 0.97 (0.54–1.75)
 Not working—other 1.00 (0.72–1.39) 1.20 (0.84–1.71)
*Adjusted for all the other variables listed in the table.
Table 2. Odds of interest in medical research participation as a healthy volunteer.
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distrust compared to whites.28 Such findings, 
which may reflect subjects’ concerns about 
being in a study but left untreated, echo 
the Tuskegee Experiments of 1932–1972.29 
More broadly, distrust of the medical system 
and medical research has been reported in 
black communities for over a decade.6,7,30,31 
Whether such distrust translates into 
less willingness to participate in medical 
research at the national level is suggested 
by our findings, but cannot be conclusively 
determined because we did not specifically 
ask about this concern.
Of note, Cottler et al. found that blacks 
were more likely to be interested in MRP 
in general and specifically more willing to 
participate in studies requiring blood and 
DNA samples.27 However, Cottler’s study 
did not make the distinction between 
respondents’ participation as healthy 
or diagnosed volunteers. Furthermore, 
our study differs with Cottler’s with 
regard to scope (national vs. seven local 
sites) and survey method (Web-based, 
self-administered vs. administered by 
community health workers).
The chief limitation of this study is that 
it is a cross-sectional survey. Like other 
surveys, it can indicate associations but not 
causal relationships. Additionally, survey 
respondents were asked about their general 
interest in participating in certain types of 
medical research. Since these survey items 
were presented to participants as hypothetical 
scenarios, responses may be different when 
actually faced with the circumstances posed. 
Nonetheless, patterns we report are consistent 
with disparate patterns of enrollment in 
clinical trials by race/ethnicity that have been 
observed objectively elsewhere.
Conclusions
In this nationally representative survey, we 
found generally high levels of interest in MRP 
that contrast with low levels of prior research 
participation among adults in the United 
States. Interest is comparatively high for research efforts that 
involve questions about nutrition, behavior, and mental health, 
and markedly lower for trials of drugs, devices, and vaccines. 
Levels of public participation in research may be increased in 
the future with greater attention to the public’s preferences for 
particular study types, and with efforts to address racial/ethnic 
disparities in interest in participating as healthy or diagnosed 
volunteers, especially among non-Hispanic black adults.
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Unadjusted odds ratio 
(95% CI)
Adjusted* odds ratio 
(95% CI)
Age (years)
 18–29 1.0 (ref) 1.0 (ref)
 30–44 0.91 (0.61–1.35) 0.78 (0.52–1.19)
 45–59 0.82 (0.54–1.25) 0.78 (0.50–1.24)
 ≥60 0.59 (0.37–0.93) 0.74 (0.40–1.37)
Gender
 Male 1.0 (ref) 1.0 (ref)
 Female 0.79 (0.61–1.03) 0.77(0.58–1.01)
Race/ethnicity
 White, non-Hispanic 1.0 (ref) 1.0 (ref)
 Black, non-Hispanic 0.56 (0.37–0.83) 0.57 (0.37–0.86)
 Hispanic 0.84 (0.56–1.27) 0.85 (0.56–1.29)
 Other, non-Hispanic 0.88 (0.51–1.52) 0.75 (0.43–1.30)
Education
 Less than high school 0.51 (0.32–0.83) 0.57 (0.35–0.92)
 High school 1.0 (ref) 1.0 (ref)
 Some college 1.36 (0.96–1.91) 1.32 (0.93–1.87)
 Bachelors degree or higher 1.65 (1.17–2.33) 1.38 (0.94–2.00)
Household income
 Up to $24,999 1.0 (ref) 1.0 (ref)
 $25,000-$49,999 0.86 (0.57–1.30) 0.70 (0.45–1.08)
 $50,000-$99,999 1.36 (0.92–2.01) 1.01 (0.64–1.60)
 $100,000 or more 1.82 (1.20–2.77) 1.10 (0.66–1.83)
Health insurance at time of survey completion
 Private 1.0 (ref) 1.0 (ref)
 Public 0.57 (0.42–0.78) 0.96 (0.64–1.43)
 Other 0.97 (0.46–2.05) 1.31 (0.58–2.96)
 None 0.69 (0.47–1.02) 0.79 (0.50–1.26)
Employment status at the time of survey completion
 Working 1.0 (ref) 1.0 (ref)
 Not working—retired 0.57 (0.39–0.83) 0.66 (0.37–1.17)
 Not working—disabled 0.51 (0.30–0.86) 0.70 (0.39–1.27)
 Not working—other 1.09 (0.78–1.51) 1.41 (0.99–2.02)
*Adjusted for all the other variables listed in the table.
Table 3. Odds of consideration of medical research participation as a diagnosed volunteer
Study type
Questions about nutrition or eating 86%
Questions about behavior 82%
Questions about mental health 80%
Medical device 75%
Medication 70%
Sample of DNA 69%
Vaccine 59%
*Respondents were able to choose more than one study type.
Table 4. Proportions of respondents likely to participate in medical research as 
diagnosed volunteers, by study type*.
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(95% CI)
Vaccine  
(95% CI)
Medical  
device  
(95% CI)
Nutrition  
survey  
(95% CI)
Behavioral 
survey  
(95% CI)
Mental health 
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DNA study 
(95% CI)
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1.0 1.0 1.0 1.0 1.0 1.0 1.0
Black, non-
Hispanic
0.61  
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1.07  
(0.67–1.70)
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(0.50–1.69)
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(0.55–1.68)
1.39  
(0.88–2.20)
Other, non-
Hispanic
0.70  
(0.40–1.24)
1.08  
(0.63–1.83)
0.92  
(0.52–1.62)
1.11  
(0.48–2.58)
1.06  
(0.52–2.15)
1.01  
(0.53–1.96)
1.00  
(0.53–1.91)
*Adjusted for age, gender, education, household income, health insurance type, and employment status.
Table 5. Adjusted odds of likelihood of research participation as diagnosed volunteer, by study type*.
